Activation of myocardial contraction by the N-terminal domains of myosin binding protein-C

Circulation Research

Volumn 98, Issue 10, 2006, Pages 1290-1298

  Herron, Todd J ^a,c   Rostkova, Elena ^a   Kunst, Gudrun ^b   Chaturvedi, Rajiv ^a,d   Gautel, Mathias ^a   Kentish, Jonathan C ^a,e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Ca 2+sensitization; Cardiac myocytes; Frank Starling mechanism; Myosin binding protein C; Sarcomere length

Indexed keywords

ACTIN; ALANINE; CALCIUM; MYOSIN; MYOSIN BINDING PROTEIN C; PROLINE; CARRIER PROTEIN; MYOSIN-BINDING PROTEIN C; PEPTIDE FRAGMENT;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; DOSE RESPONSE; FORCE; HEART CONTRACTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; RAT; SARCOMERE; STARLING LAW; ANIMAL; DRUG EFFECT; GENETICS; HEART MUSCLE CELL; HEART VENTRICLE; METABOLISM; MUSCLE FIBRIL; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TISSUE DISTRIBUTION; ULTRASTRUCTURE;

ANIMALS; CALCIUM; CARRIER PROTEINS; HEART VENTRICLES; HUMANS; MICE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; MYOFIBRILS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; RATS; SARCOMERES; TISSUE DISTRIBUTION;

EID: 33744993933     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000222059.54917.ef     Document Type: Article

References (31)

1. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M, for the EUROGENE Heart Failure Project. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 2003;107:2227-2232.
2. Flashman E, Redwood C, Moolman-Smook J, Watkins H. Cardiac myosin binding protein C: its role in physiology and disease. Circ Res. 2004;94:1279-1289.
3. Korte FS, McDonald KS, Harris SP, Moss RL. Loaded shortening, power output, and rate of force redevelopment are increased with knockout of cardiac myosin binding protein-C. Circ Res. 2003;93:752-758.
4. Palmer BM, Georgakopoulos D, Janssen PM, Wang Y, Alpert NR, Belardi DF, Harris SP, Moss RL, Burgon PG, Seidman CE, Seidman JG, Maughan DW, Kass DA. Role of cardiac myosin binding protein C in sustaining left ventricular systolic stiffening. Circ Res. 2004;94:1249-1255.
5. Gruen M, Prinz H, Gautel M. cAPK-phosphorylation controls the interaction of the regulatory domain of cardiac myosin binding protein C with myosin-S2 in an on-off fashion. FEBS Lett. 1999;453:254-259.
6. Weisberg A, Winegrad S. Alteration of myosin cross bridges by phosphorylation of myosin-binding protein C in cardiac muscle. Proc Natl Acad Sci U S A. 1996;93:8999-9003.
7. Kentish JC, McCloskey DT, Layland J, Palmer S, Leiden JM, Martin AF, Solaro RJ. Phosphorylation of troponin-I by protein kinase A accelerates relaxation and cross-bridge cycle kinetics in mouse ventricular muscle. Circ Res. 2001;88:1059-1065.
8. Squire JM, Luther PK, Knupp C. Structural evidence for the interaction of C-protein (MyBP-C) with actin and sequence identification of a possible actin-binding domain. J Mol Biol. 2003;331:713-724.
9. Kulikovskaya I, McClellan G, Flavigny J, Carrier L, Winegrad S. Effect of MyBP-C binding to actin on contractility in heart muscle. J Gen Physiol. 2003;122:761-774.
10. Konhilas JP, Irving TC, de Tombe PP. Frank-Starling law of the heart and the cellular mechanisms of length-dependent activation. Pflugers Arch. 2002;445:305-310.
11. Allen DG, Kentish JC. The cellular basis of the length-tension relation in cardiac muscle. J Mol Cell Cardiol. 1985;17:821-840.
12. 2+ sensitivity of tension at short sarcomere length. Circ Res. 1995;77:199-205.
13. 2+ activation in cardiac muscle: some remaining questions. J Muscle Res Cell Motility. 2005;26:199-212.
14. Herron TJ, Kunst G, Gautel M, Kentish JC. Regulation of skinned cardiac myocyte contractility by the N-terminal region of myosin-binding protein C. J Muscle Res Cell Motility. 2003;24:328 Abstract.
15. Gruen M, Gautel M. Mutations in β-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C. J Mol Biol. 1999;286:933-949.
16. Kunst G, Kress KR, Gruen M, Uttenweiler D, Gautel M, Fink RHA. Myosin binding protein C, a phosphorylation-dependent force regulator in muscle that controls the attachment of myosin heads by its interaction with myosin S2. Circ Res. 2000;86:51-58.
17. 2+ activation and relaxation in rat and guinea-pig skinned trabeculae. Circ Res. 1998;83:179-186.
18. Herron TJ, Korte FS, McDonald KS. Power output is increased after phosphorylation of myofibrillar proteins in rat skinned cardiac myocytes. Circ Res. 2001;89:1184-1190.
19. Brenner B, Eisenberg E. Rate of force generation in muscle: correlation with actomyosin ATPase activity in solution. Proc Natl Acad Scu U S A. 1986;83:3542-3546.
20. Freiburg A, Gautel M. A molecular map of the interactions between titin and myosin-binding protein C: implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur J Biochem. 1996;235:317-323.
21. Lange S, Xiang F, Yakovenko A, Vihola A, Hackman P, Rostkova E, Kristensen J, Brandmeier B, Franzen G, Hedberg B, Gunnarsson LG, Hughes SM, Marchand S, Sejersen T, Richard I, Edstrom L, Ehler E, Udd B, Gautel M. The kinase domain of titin controls muscle gene expression and protein turnover. Science. 2005;308:1599-1603.
22. Rundell VLM, Manaves V, Martin AF, de Tombe PP. Impact of β-myosin heavy chain isoform expression on cross-bridge cycling kinetics. Am J Physiol Heart Circ Physiol. 2005;288:H896-H903.
23. Chandra M, Kim JJ, Solaro RJ. An improved method for exchanging troponin subunits in detergent skinned rat cardiac fiber bundles. Biochem Biophys Res Commun. 1999;263:219-223.
24. Wolff MR, Mcdonald KS, Moss RL. Rate of tension development in cardiac muscle varies with level of activator calcium. Circ Res. 1995;76:154-160.
25. Harris SP, Rostkova E, Gautel M, Moss RL. Binding of myosin binding protein-C to myosin subfragment S2 affects contractility independent of a tether mechanism. Circ Res. 2004;95:930-936.
26. van der Velden J, de Jong JW, Owen VJ, Burton PBJ, Stienen GJ. Effect of protein kinase A on calcium sensitivity of force and its sarcomere length dependence in human cardiomyocytes. Cardiovasc Res. 2000;46:487-495.
27. Flavigny J, Souchet M, Sebillon P, Berrebi-Bertrand I, Hainque B, Mallet A, Bril A, Schwartz K, Carrier L. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophie cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes. J Mol Biol. 1999;294:443-456.
28. Woodhead JL, Zhao FQ, Craig R, Egelman EH, Alamo L, Padron R. Atomic model of a myosin filament in the relaxed state. Nature. 2005;436:1195-1199.
29. Schaub MC, Hefti MA, Zuellig RA, Morano I. Modulation of contractility in human cardiac hypertrophy by myosin essential light chain isoforms. Cardiovascular Res. 1998;37:381-404.
30. 2+ activation in skinned cardiac muscle. J Mol Cell Cardiol. 1999;31:2115-2125.
31. Cazorla O, Szilagyi S, Vignier N, Salazar G, Kramer E, Vassort G, Carrier L, Lacampagne A. Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice. Cardiovascular Res. 2006;69:370-380.